J. Neurosci. Res. volume 86, issue 11, P2499-2504 2008 DOI: 10.1002/jnr.21695 View full text
Bruce A. Citron, John S. Dennis, Ross S. Zeitlin, Valentina Echeverria

Abstract: Altered gene expression occurs in central nervous system disorders, including Alzheimer's disease (AD). Transcription factor Sp1 may be involved insofar as it can regulate the expression of several AD-related proteins, including amyloid precursor protein (APP) and tau. Sp1 could itself be regulated by inflammatory and other factors associated with AD, such as interleukin-1beta. We measured an almost threefold elevation in the number of mRNA molecules of this cytokine in the AD frontal cortex. Sp1 mRNA was foun…

expand abstract